Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


How to automate the analysis of MS data for biotherapeutics characterization

15 Jul 2014 - 15 Jul 2014 - Webinar



Bookmark and Share


Tuesday, July 15, 2:30 PM - 3:30 PM BST
Register for this webinar

As the use of mass spectrometry (MS) to characterize biotherapeutics increases throughout the entire discovery and development process, organizations are being deluged with data and are struggling to find new ways to automate data processing, analysis, and reporting. The fact that MS laboratories often employ instruments from a variety of vendors, each with its own data processing software, contributes significantly to the difficulty in streamlining and automating analysis and reporting. To address this data analysis bottleneck, there is a clear need for vendor agnostic software that can standardize and automate data processing of MS data from any source. In this live webinar, use cases on improving the characterization of biotherapeutics using Genedata Expressionist software will be presented. This will include: 

Intact protein analysis
Peptide mapping
Glycopeptide analysis
Disulphide bond analysis
Sequence variant analysis 

WHO SHOULD ATTEND
Bioanalytical scientists who are characterizing biopharmaceuticals using Mass Spectrometry 

SPEAKER
Joe Shambaugh, Scientific Consultant, Genedata Inc. 



Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!